The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
Jens Bauer,Natalie Kohler,Yacine Maringer,Philip Bucher,Tatjana Bilich,Melissa Zwick,Severin Dicks,Annika Nelde,Marissa Dubbelaar,Jonas Scheid,Marcel Wacker,Jonas J. Heitmann,Sarah Schroeder,Jonas Rieth,Monika Denk,Marion Richter,Reinhild Klein,Irina Bonzheim,Julia Luibrand,Ursula Holzer,Martin Ebinger,Ines B. Brecht,Michael Bitzer,Melanie Boerries,Helmut R. Salih,Hans-Georg Rammensee,Stephan Hailfinger,Juliane S. Walz CANCER RESEARCH(2022)
AI 理解论文
溯源树
样例